Valeska Schroeder

Valeska has been a Managing Director of KCK’s Medical Technologies Investment Group since 2016. KCK is a single-family fund investing in a range of industries in private equity, growth capital, and venture capital, including a focus in medical technology. Valeska is a board member for KCK portfolio companies, including Cerapedics, Aerin Medical and BioInspire and a board observer for Intuity Medical and Reflexion Medical. Before joining KCK, Valeska held roles in product development, program management, and marketing in medical device companies, including VitalConnect, Acclarent, and NDC. Valeska obtained a BS, MS, and PhD from University of California at Berkeley in Materials Science and Engineering.